Company: EHC
Filing Date: 2025-10-31
Form Type: 10-Q
Source: 0000785161-25-000115
Chunk: 52

Company: Encompass Health Corp
Filing Date: 2025-10-31
Form: 10-Q
Item: Part I, Item 1
Chunk 52
---
, 2024Credit Agreement—  Advances under revolving credit facility$80.0 $20.0 Bonds payable—5.75% Senior Notes due 2025— 99.8 4.50% Senior Notes due 2028791.1 788.4 4.75% Senior Notes due 2030786.2 784.2 4.625% Senior Notes due 2031393.3 392.5 Other notes payable81.5 94.5 Finance lease obligations300.8 318.4 2,432.9 2,497.8 Less: Current portion(39.0)(138.6)Long-term debt, net of current portion$2,393.9 $2,359.2 The following chart shows scheduled principal payments due on long-term debt for the next five years and thereafter (in millions):Face AmountNet AmountOctober 1 through December 31, 2025$8.0 $8.0 202639.4 39.4 2027126.1 126.1 2028833.0 824.1 202941.8 41.7 2030847.2 833.4 Thereafter566.9 560.2 Total$2,462.4 $2,432.9 In September 2025, we redeemed the remaining $100 million of the outstanding principal balance of our 5.75% Senior Notes due 2025 at maturity using cash on hand and capacity under our revolving credit facility.

6.Redeemable Noncontrolling Interests

The following is a summary of the activity related to our Redeemable noncontrolling interests (in millions):Nine Months Ended September 30,20252024Balance at beginning of period$56.5 $42.0 Net income attributable to noncontrolling interests6.3 4.2 Distributions declared(8.4)(7.7)Contribution to joint venture— 18.0 Balance at end of period$54.4 $56.5 

13

Encompass Health Corporation and SubsidiariesNotes to Condensed Consolidated Financial Statements

The following table reconciles the net income attributable to nonredeemable Noncontrolling interests, as recorded in the shareholders’ equity section of the condensed consolidated balance sheets, and the net income attributable to Redeemable non